TB-CAPT: Start of recruitment for CORE and HIV trials
The TB-CAPT consortium successfully enrolled the first patients in two of its three clinical trials: the CORE trial, which aims at assessing the impact of making the Molbio MTB assays on the Truenat platform available at the primary healthcare level, and the TB-CAPT EXULTANT trial which will assess the impact of an expanded testing strategy for diagnosing TB amongst people living with HIV. Coordinated by FIND, the global alliance for diagnostics, the rationale of the TB-CAPT project is to provide evidence for impactful implementation of tuberculosis (TB) and TB/HIV co-infection diagnostic strategies, including drug-susceptibility testing.